已收盤 10-03 16:00:00 美东时间
+0.780
+1.50%
California Resources Corporation announced the redemption of its 7.125% Senior Notes due 2026 on October 10, 2025. The redemption price is 100.000% of the principal amount plus accrued interest. After the redemption, no 2026 Notes will remain outstanding. The company highlights this action as part of its commitment to maintaining a strong balance sheet.
09-30 21:00
Genmab A/S (NASDAQ: GMAB) on Monday agreed to acquire Merus N.V.
09-29 22:15
在创新药投资的淘金浪潮中,真正值得长期押注的,永远是那些能够定义赛道、并拥有清晰商业化路径的破局者。 当行业从概念炒作回归价值本质,一家聚焦肿瘤耐药这一核心难题...
09-26 09:36
California Resources Corporation (CRC) plans to offer $400 million in senior unsecured notes due 2034 to fund its pending acquisition of Berry Corporation. The notes will be guaranteed by CRC's subsidiaries and proceeds will be used to repay Berry's existing debt and cover merger-related expenses. The notes are subject to mandatory redemption if the merger is not completed by March 14, 2026, or if the deal is terminated. Offered only to qualified...
09-24 12:07
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从34美元升至35美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.5美元升至7.75美元
09-23 09:52
California Resources Corporation (CRC) has published its 2024 Sustainability Report, highlighting its progress in sustainability efforts and commitment to California's natural resources. As the largest oil and gas producer in the state following its merger with Aera Energy, CRC introduced its Responsible Net Zero (RNZ) strategy, aligned with the United Nations Sustainable Development Goals. Key achievements include securing California's first EPA...
09-18 15:03
In the current session, the stock is trading at $56.50, after a 0.77% increase....
09-18 02:00
今日重点评级关注:HC Wainwright & Co.:维持Orion Energy Sys"买入"评级,目标价从2美元升至20美元;高盛:维持Amylyx Pharmaceuticals"买入"评级,目标价从10美元升至20美元
09-17 10:15
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
Mizuho analyst Nitin Kumar maintains California Resources (NYSE:CRC) with a Outperform and raises the price target from $64 to $65.
09-16 00:13